Cyltezo Kit
Product Images NDC 0597-0495

Product Visual Gallery

This gallery contains 36 technical images submitted to the FDA as part of the official labeling for Cyltezo (NDC 0597-0495). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Cyltezo 01)

A line graph presenting the percentage of ACR 20 responders over time (weeks) comparing treatment with 40 mg every other week versus placebo. The solid line with square markers represents the 40 mg treatment group, showing a higher and sustained percentage of responders compared to the placebo group, shown with a dashed line with circle markers.*

FDA Label Image

Figure 2 (Cyltezo 02)

A line graph comparing percent ASAS 20 response over 26 weeks for two groups: Adalimumab (N=208) and Placebo (N=107). The Adalimumab group shows a higher response rate throughout, peaking around 50-60%, while the Placebo group's response remains below 30%. The x-axis represents time in weeks, and the y-axis represents the percentage of ASAS 20 response.*

FDA Label Image

Figure (Cyltezo 03)

FDA Label Image

Figure (Cyltezo 04)

An instructional illustration detailing parts of a Cyltezo adalimumab-adbm injection pen kit. Labeled components include the injection button, grip, medicine window, cap, tip (needle guard), and the internal plunger. The pen is shown with the cap removed to reveal the tip.*

FDA Label Image

Step 1 (Cyltezo 05)

An instructional diagram showing four items labeled a, b, c, and d: a prefilled syringe or injector pen (a), a red biohazard sharps container with a white lid (b), a cotton ball or gauze pad (c), and an alcohol prep pad or wipe (d). The image appears to illustrate components involved in an injection process or disposal procedure.*

FDA Label Image

Step 2 (Cyltezo 06)

An instructional diagram showing a cylindrical medicine tube labeled 'Medicine' and highlighting the location of the 'Expiration date,' indicated by the text 'EXP MMMYYYY' on the tube's label. The illustration uses simple graphics to point out these two features.*

FDA Label Image

Step 3 (Cyltezo 07)

An illustration depicting a pair of hands being washed under running water from a faucet. Soap bubbles are visible on the hands, emphasizing thorough handwashing. The image visually demonstrates the proper technique for hand hygiene.*

FDA Label Image

Step 4 (Cyltezo 08)

Illustration showing labeled injection sites for administering a drug. The diagram highlights the abdomen and thighs as preferred injection areas on a seated person, with dashed circles indicating the specific regions for injection.*

FDA Label Image

Step 5 (Cyltezo 09)

An instructional illustration showing a hand applying a small white pad or swab to an area of skin marked by a dotted circle, possibly indicating a step in preparing or cleaning the skin prior to injection or medical procedure.*

FDA Label Image

Step 6 (Cyltezo 10)

An instructional illustration showing two hands preparing a cylindrical device, likely an injection pen. One hand holds the device horizontally with a capped needle end, while the other hand removes or attaches the needle cap by pulling it straight off, indicated by an arrow pointing away from the device.*

FDA Label Image

Step 7 (Cyltezo 11)

Instructional illustration showing a hand squeezing around the injection site on the skin, with a label pointing to the area indicating 'Squeeze around injection site.' This visual guides how to properly handle the injection site for the drug Cyltezo (adalimumab-adbm) kit by Boehringer Ingelheim Pharmaceuticals, Inc.*

FDA Label Image

Step 8 (Cyltezo 12)

An instructional diagram showing how to use a medication pen injector from the Cyltezo kit. It depicts a hand positioning the pen at a 90-degree angle to the skin surface with an arrow indicating to press and hold the tip for injection. The inset zooms in on the tip area with an instruction to press and hold during use.*

FDA Label Image

Step 9 (Cyltezo 13)

An instructional illustration showing how to use an injection pen for Cyltezo (adalimumab-adbm) kit. It depicts a hand pressing the injection button and holding the pen against the skin, with a close-up of the plunger inside the device. Instructions advise to keep holding the pen and slowly count to 10.*

FDA Label Image

Step 10 (Cyltezo 14)

An instructional diagram showing how to administer an injection using a prefilled pen. The illustration depicts a hand holding a pen device at a right angle to the skin, with another hand's finger positioned to lift the skin. An inset shows a close-up detail of the pen needle insertion mechanism.*

FDA Label Image

Step 10 (Cyltezo 15)

An illustration showing a hand holding a cotton ball or gauze pad, pressing it against a forearm. This instructional image likely demonstrates proper skin preparation or post-injection care for administering Cyltezo (adalimumab-adbm) injection kit.*

FDA Label Image

Step 11 (Cyltezo 16)

Illustration showing a hand disposing of a used syringe or pen into a red sharps disposal container marked with a black biohazard symbol. The image represents proper disposal of medical sharps, consistent with safe handling instructions for injectable drugs like Cyltezo (adalimumab-adbm) kit.*

FDA Label Image

Figure (Cyltezo 17)

FDA Label Image

Figure (Cyltezo 18)

An illustrated diagram of a syringe showing labeled parts including the plunger rod, grip, plunger, medicine inside the barrel, needle, and cap. The illustration visually identifies each component of the syringe mechanism in a straightforward layout.*

FDA Label Image

Step 1 (Cyltezo 19)

An instructional illustration showing four items labeled a through d: a syringe with a green plunger (a), a red sharps disposal container with a biohazard symbol (b), a round cotton pad (c), and a folded square gauze (d). This diagram likely demonstrates components or steps related to drug administration preparation.*

FDA Label Image

Step 2 (Cyltezo 20)

An instructional illustration showing a syringe labeled with 'Medicine' and a magnified view of its label indicating where to find the expiration date and lot number. The label displays the format 'MONTH YEAR' for the expiration date and 'EXP. Lot' for the lot information.*

FDA Label Image

Step 3 (Cyltezo 21)

An instructional illustration showing two hands being washed under running water, with soap bubbles visible on the hands. The image emphasizes hand cleaning technique.*

FDA Label Image

Step 4 (Cyltezo 22)

An illustration showing recommended injection sites on a seated human figure for a subcutaneous injection. The labeled areas include the abdomen and the thighs, each marked with dashed line ovals indicating suitable injection locations.*

FDA Label Image

Step 5 (Cyltezo 23)

An illustration showing a hand holding a medical patch or device above a marked circular area on the skin, suggesting placement or application instructions for a topical or transdermal product.*

FDA Label Image

Step 6 (Cyltezo 24)

An instructional illustration showing hands removing the cap from a prefilled injection pen, likely part of a kit for subcutaneous administration.*

FDA Label Image

Step 7 (Cyltezo 25)

An instructional illustration showing a hand squeezing the skin around an injection site, with text indicating to "Squeeze around injection site and hold." This image is part of guidance on proper injection technique, related to the Cyltezo adalimumab-adbm kit.*

FDA Label Image

Step 8 (Cyltezo 26)

Instructional diagram showing hands inserting a needle at a 45-degree angle into the skin of an arm. The image guides on the correct angle for needle insertion, likely related to the administration procedure of Cyltezo adalimumab-adbm kit.*

FDA Label Image

Step 9 (Cyltezo 27)

Instructional illustration showing a hand slowly pushing the plunger rod of a syringe, with an inset magnifying the plunger tip to demonstrate the correct injection technique.*

FDA Label Image

Step 10 (Cyltezo 28)

An instructional illustration showing a hand removing a needle from a device at a 45-degree angle above a surface, indicating the proper technique to remove the needle after use. The image is related to the administration process of a medication kit.*

FDA Label Image

Step 10 (Cyltezo 29)

An illustration depicting a hand holding a piece of cotton or gauze near the skin surface, suggesting preparation or care, possibly related to medication administration or injection site care.*

FDA Label Image

Step 11 (Cyltezo 30)

Illustration showing a hand disposing of a used syringe into a red sharps disposal container marked with a black biohazard symbol. The image emphasizes safe syringe disposal.*

FDA Label Image

Figure (Cyltezo 31)

FDA Label Image

Principal Display Panel (Kit Carton)

Cyltezo 40 mg/0.8 mL injection kit packaging label showing two single-dose prefilled syringes for subcutaneous use only. The label includes the proprietary name Cyltezo, the generic name adalimumab-adbm, and the labeler Boehringer Ingelheim Pharmaceuticals, Inc. It warns that the needle cap contains dry natural rubber and includes a note to pharmacists about the enclosed medication guide. The NDC number 0597-0370-82 is also displayed.*

FDA Label Image

Principal Display Panel (Kit Carton)

Carton packaging label for Cyltezo (adalimumab-adbm) injection, 40 mg/0.8 mL, a single-dose prefilled syringe kit. The label specifies subcutaneous use only and includes the NDC 0597-0370-72. The labeler is Boehringer Ingelheim Pharmaceuticals, Inc. The label shows the product name, strength, dosage form, and an image of the syringe with a green needle cap.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Cyltezo (adalimumab-adbm) injection kit, 20 mg/0.4 mL. The carton indicates it contains 2 single-dose prefilled syringes for subcutaneous use only. The labeler is Boehringer Ingelheim Pharmaceuticals, Inc. The label includes syringe images, dosage strength, and usage instructions for pharmacists. The design features the Cyltezo logo with blue and green colors.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Cyltezo (adalimumab-adbm) injection 10 mg/0.2 mL kit by Boehringer Ingelheim Pharmaceuticals, Inc. The carton contains 2 single-dose prefilled syringes for subcutaneous use only. Label includes an image of a prefilled syringe with a green needle cap, NDC 0597-0400-89, and pharmacist instructions to dispense the entire carton as a unit.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Cyltezo Pen injection, adalimumab-adbm, 40 mg/0.8 mL prefilled single-dose pens. The kit contains 2 single-dose pens for subcutaneous use only and is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. The label includes usage instructions, a product image, and a note for pharmacists to dispense the entire carton as a unit with an enclosed medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.